![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
Title
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
Phase ![sort descending](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/arrow_down.gif)
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
Protocol IDs
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
RPCI-RP-9815
NCI-V99-1527, NCT00003816, RP 98-15
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
UARK 2003-26
NCT00090493
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
RPCI-I-72806
I 72806, NCT00536601
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
In-Vivo Activated T-Cell Depletion to Prevent GVHD
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
0705-20 IUCRO-0196
NCT00594308
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Total-Body Irradiation With Or Without Fludarabine Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
FHCRC-1813.00
5666, NCT00075478
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II or Stage III Multiple Myeloma
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
FHCRC-2004.00
6004, MEDIMMUNE-FHCRC-2004.00, NCT00217438
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
CA200-004
KAG-301, NCT00546780
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
2006-05
NCT00573391
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
2006-15
NCT00574080
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Tandem Transplantation in Multiple Myeloma (MM) Patients With <12 Months of Prior Treatment
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
25009
59306670 7R01CA115399, NCT00670631
![](https://webarchive.library.unt.edu/eot2008/20081024062509im_/http://www.cancer.gov/images/spacer.gif)
|
|